Publications by authors named "Muath Almaslamani"

Claim this Profile
A
Ac-NOTA-trastuzumab human dosimetry using inter-radionuclide and biological half-life based allometric extrapolation method.
Muath Almaslamani, Kangsan Kim, Kwang Il Kim, Ilhan Lim, Hyun-Ah Kim

EJNMMI Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET image nonuniformity texture features for metastasis risk prediction in osteosarcoma.
Muath Almaslamani, Byung-Hyun Byun, Kanghyon Song, Chang-Bae Kong, Sang-Keun Woo

Nucl Med Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning-based radiolabelled compound-protein interaction prediction for NDUFS1-targeting radiopharmaceutical discovery.
Muath Almaslamani, Jingyu Yang, Chi Soo Kang, Choong Mo Kang, Jung Mi Park

EJNMMI Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radionuclide-Aided Improvement of the Therapeutic Efficacy of Novel Antibody-Drug Conjugates against HER2-Expressing Cancers.
Chi Soo Kang, Do Hyeon Kim, Hwisoo Lim, Sunkyo Kim, Muath Almaslamani

Mol Pharm· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning-based organ-wise dosimetry of Cu-DOTA-rituximab through only one scanning.
Kangsan Kim, Jingyu Yang, Muath Almaslamani, Chi Soo Kang, Inki Lee

Sci Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis